Your browser doesn't support javascript.
loading
Sex Differences in Genomic Features of Hepatitis B-Associated Hepatocellular Carcinoma With Distinct Antitumor Immunity.
Xu, Chungui; Cheng, Shaoyan; Chen, Kun; Song, Qianqian; Liu, Chang; Fan, Chunsun; Zhang, Ruochan; Zhu, Qing; Wu, Zhiyuan; Wang, Yuting; Fan, Jian; Zheng, Hongwei; Lu, Lingling; Chen, Taoyang; Zhao, Hong; Jiao, Yuchen; Qu, Chunfeng.
Affiliation
  • Xu C; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Immunology Department, National Cancer Center, National Clinical Research Center for Cancer,
  • Cheng S; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Immunology Department, National Cancer Center, National Clinical Research Center for Cancer,
  • Chen K; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Immunology Department, National Cancer Center, National Clinical Research Center for Cancer,
  • Song Q; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Liu C; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Immunology Department, National Cancer Center, National Clinical Research Center for Cancer,
  • Fan C; Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong, Jiangsu Province, China.
  • Zhang R; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Immunology Department, National Cancer Center, National Clinical Research Center for Cancer,
  • Zhu Q; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.
  • Wu Z; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Immunology Department, National Cancer Center, National Clinical Research Center for Cancer,
  • Wang Y; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Immunology Department, National Cancer Center, National Clinical Research Center for Cancer,
  • Fan J; Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong, Jiangsu Province, China.
  • Zheng H; Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong, Jiangsu Province, China.
  • Lu L; Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong, Jiangsu Province, China.
  • Chen T; Qidong Liver Cancer Institute, Qidong People's Hospital, Qidong, Jiangsu Province, China.
  • Zhao H; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Department of Hepatobiliary Surgery, National Cancer Center, National Clinical Research Cente
  • Jiao Y; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China. Electronic address: jiaoyuchen@cicams.ac.cn.
  • Qu C; State Key Lab of Molecular Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China; Immunology Department, National Cancer Center, National Clinical Research Center for Cancer,
Cell Mol Gastroenterol Hepatol ; 15(2): 327-354, 2023.
Article in En | MEDLINE | ID: mdl-36272708
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Aflatoxins / Hepatitis B / Liver Neoplasms Type of study: Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Cell Mol Gastroenterol Hepatol Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Carcinoma, Hepatocellular / Aflatoxins / Hepatitis B / Liver Neoplasms Type of study: Risk_factors_studies Limits: Animals / Female / Humans / Male Language: En Journal: Cell Mol Gastroenterol Hepatol Year: 2023 Document type: Article